These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26921012)

  • 1. Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.
    İşgüder R; Ağın H; Ceylan G; Bayram N; Devrim İ
    Am J Infect Control; 2016 Jun; 44(6):734-5. PubMed ID: 26921012
    [No Abstract]   [Full Text] [Related]  

  • 2. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.
    Celebi S; Hacimustafaoglu M; Koksal N; Ozkan H; Cetinkaya M
    Pediatr Int; 2010 Jun; 52(3):410-4. PubMed ID: 20003141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
    Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
    Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
    Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
    Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of the tigecycline-colistin association in the treatment of multi-resistant Acinetobacter baumannii meningitis].
    Regaieg K; Bahloul M; Turki O; Mnif B; Bouaziz M
    Med Mal Infect; 2017 Mar; 47(2):175-177. PubMed ID: 28215823
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
    Katragkou A; Roilides E
    J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S; Charra B; Hachimi A; Benslama A
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract]   [Full Text] [Related]  

  • 17. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
    J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
    Khawcharoenporn T; Apisarnthanarak A; Mundy LM
    Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.
    Gounden R; Bamford C; van Zyl-Smit R; Cohen K; Maartens G
    BMC Infect Dis; 2009 Mar; 9():26. PubMed ID: 19272139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.